Back to search
FDAFDA · Food and drugs·Recall number D-0988-2022

Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01

Published June 15, 2022 · Recall initiated: May 18, 2022

Summary

FDA records drug Class III recall D-0988-2022, published June 15, 2022 and initiated May 18, 2022. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 3109 cartons; Lot: Lot #:100022404, Exp Date 10/2022; Lot #:100023333, Exp Dat 12/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA Inc
Distributor
Product was distributed nationwide in the US Market
Lot
Lot #:100022404, Exp Date 10/2022; Lot #:100023333, Exp Dat 12/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01 recalled?

Yes. FDA published recall D-0988-2022 on June 15, 2022. Reported hazard: Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter